https://www.businesswire.com/news/home/20250618093628/en/Saptalis-Pharmaceuticals-Launches-Fluoxetine-Oral-Solution-USP-20-mg5-mL
Saptalis Pharmaceuticals Launches Fluoxetine Oral Solution, USP 20 mg/5 mL
Saptalis Pharmaceuticals, LLC. is pleased to announce the commercial launch of Fluoxetine Oral Solution, USP 20 mg/5 mL, a prescription-only selective seroto...
oral solutionpharmaceuticalslaunchesfluoxetine